Huang X, Wu Y, Ni Y, Xu H, He Y
Some GLP-1 products are FDAapproved for weight loss, others are approved for diabetes, and insurers often classify obesity treatments under restrictive benefit rules
Why GLP-1 Medications Work So Well: They Address the Real Problem: Most weight loss approaches fail because they fight against your bodys biology: Calorie restriction triggers stronger hunger signals Your metabolism slows to conserve energy Cravings intensify as weight decreases Willpower alone cant overcome these biological responses GLP-1 medications work with your biology: Reduce hunger signals at the source Increase natural satiety after eating Decrease food cravings and obsessive food thoughts Make portion control feel natural, not forced This is why GLP-1 therapy produces results that calorie restriction alone cannot achieve
Severe Gastrointestinal Disease People with inflammatory bowel disease, Crohns disease, or other serious GI conditions were largely excluded from retatrutide trials
Once approved, insurance coverage will be subject to individual plan formularies and medical necessity criteria
In the retatrutide trials, the ratio of fat loss to lean loss was favorable compared to caloric restriction alone, where lean mass can represent 25-35% of total weight lost